Biosante Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Biosante Pharmaceuticals Inc
CIK #0001023024
EDGAR Form CIK 2011 - 2025
10-K [0001023024]
10-Q [0001023024]
3 [0001023024]
4 [0001023024]
5 [0001023024]
8-K [0001023024]
SC 13D [0001023024]
SC 13G [0001023024]
Form 13D/13G Filer Form 13D/13G Subject Filed
Integrated Core Strategies US LLC ANI Pharmaceuticals Inc [2025-06-04]
Millennium Management LLC ANI Pharmaceuticals Inc [2025-01-21]
Vanguard Group Inc ANI Pharmaceuticals Inc [2024-02-13]
Rubric Capital Management LP ANI Pharmaceuticals Inc [2024-02-12]
Esjay LLC ANI Pharmaceuticals Inc [2022-03-02]
Allianz Global Investors US Holdings LLC ANI Pharmaceuticals Inc [2018-02-15]
Allianz Global Investors US Holdings LLC ANI Pharmaceuticals Inc [2017-02-14]
Consonance Capital Management LP ANI Pharmaceuticals Inc [2015-02-17]
BlackRock Inc ANI Pharmaceuticals Inc [2015-02-03]
Marshbanks Tracy ANI Pharmaceuticals Inc [2015-02-03]
View All
Form 3/4/5 Subject 2011 - 2025
Thoma Jeanne
ANI Pharmaceuticals Inc
Pera Antonio R
Shanmugam Muthusamy
Leonard Matthew J
Gassert Chad
Walsh Patrick D
Haughey Thomas
Rowland Thomas Andrew
Carey Stephen P
Lalwani Nikhil
Gutwerg Ori
Cook Meredith
Tannenbaum Renee P
Mutz Christopher
Davis Krista
Marken James G.
Meridian Venture Partners II, Co.
Meridian Venture Partners II LP
Brown Robert E. JR
Meridian Venture Partners II GP, L.P.
Nash David
Schrepfer Robert W
Przybyl Arthur
Penn Thomas A.
Marshbanks Tracy
Holubow Fred
Raynor Daniel
Lankau Peter A
Arnold Charlotte C.
Mangano Ross J
Jamnick Robert J.
Rosenow Edward C III
Sullivan Louis W
Sherwin Stephen A
Potts John T Jr
Snabes Michael C
Simes Stephen M
Donenberg Phillip B.
Terms | Privacy | Guide
tony@aum13f.com